New ‘safer opioid’ delivers pain relief without addiction risk in early tests

Researchers at NIDA and NIH developed a new opioid derivative, DFNZ, showing strong pain relief without addiction risks or respiratory depression in early tests. The study highlights potential for safer opioid alternatives for chronic pain and overdose prevention.